Aurangabad, India

Manish Solanki



 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Manish Solanki

Introduction

Manish Solanki is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ketolide compounds. His research focuses on developing compounds that have antimicrobial activity, which is crucial in combating microbial infections.

Latest Patents

Manish Solanki holds a patent for ketolide compounds, specifically designed to provide pharmaceutical compositions that can treat or prevent microbial infections. The patent details the compounds of Formula (I) and their various forms, including pharmaceutically acceptable salts, solvates, hydrates, polymorphs, and stereoisomers. The invention emphasizes the importance of these compounds in the medical field, showcasing their potential to improve health outcomes.

Career Highlights

Currently, Manish Solanki is associated with Wockhardt Limited, a prominent pharmaceutical company. His work at Wockhardt has allowed him to focus on innovative solutions in the pharmaceutical industry. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in antimicrobial therapies.

Collaborations

Throughout his career, Manish has collaborated with talented individuals such as Bharat Kalidas Trivedi and Prasad Keshav Deshpande. These collaborations have fostered a creative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Manish Solanki's contributions to the field of pharmaceuticals through his innovative work on ketolide compounds highlight his commitment to improving health outcomes. His ongoing efforts at Wockhardt Limited and collaborations with fellow inventors underscore the importance of teamwork in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…